Skip to main content
. 2017 May 26;8(43):74139–74158. doi: 10.18632/oncotarget.18274

Figure 8. The risk score analysis of 449 PTC patients.

Figure 8

(A) top: survival status of PTC patients; middle: risk score of lncRNAs signature; bottom: risk score of 3 lncRNAs; (B) top: the diagnostic significance of risk score to survival outcome; bottom: the association of risk score with OS.